NO20002967L - Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor - Google Patents

Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor

Info

Publication number
NO20002967L
NO20002967L NO20002967A NO20002967A NO20002967L NO 20002967 L NO20002967 L NO 20002967L NO 20002967 A NO20002967 A NO 20002967A NO 20002967 A NO20002967 A NO 20002967A NO 20002967 L NO20002967 L NO 20002967L
Authority
NO
Norway
Prior art keywords
group
atom
represent
alkyl
oxygen
Prior art date
Application number
NO20002967A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002967D0 (no
Inventor
Roland Maier
Peter Mueller
Gebhard Schilcher
Gebhard Adelgoss
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20002967D0 publication Critical patent/NO20002967D0/no
Publication of NO20002967L publication Critical patent/NO20002967L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Cardiology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20002967A 1997-12-10 2000-06-09 Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor NO20002967L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754796A DE19754796A1 (de) 1997-12-10 1997-12-10 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
PCT/EP1998/007965 WO1999029669A1 (de) 1997-12-10 1998-12-08 Von azacycloalkanen abgeleitete urethane, ihre thio- und dithioanaloga, deren herstellung und deren verwendung als 2,3-epoxisqualen-lanosterol-cyclase inhibitoren

Publications (2)

Publication Number Publication Date
NO20002967D0 NO20002967D0 (no) 2000-06-09
NO20002967L true NO20002967L (no) 2000-08-09

Family

ID=7851381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002967A NO20002967L (no) 1997-12-10 2000-06-09 Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor

Country Status (27)

Country Link
EP (1) EP1060162B1 (et)
JP (1) JP3418688B2 (et)
KR (1) KR20010032977A (et)
CN (1) CN1281434A (et)
AR (1) AR017827A1 (et)
AT (1) ATE234816T1 (et)
AU (1) AU1759499A (et)
BG (1) BG104500A (et)
BR (1) BR9813495A (et)
CA (1) CA2309388A1 (et)
CO (1) CO5370694A1 (et)
DE (2) DE19754796A1 (et)
DK (1) DK1060162T3 (et)
EA (1) EA200000631A1 (et)
EE (1) EE200000342A (et)
ES (1) ES2190130T3 (et)
HR (1) HRP20000377A2 (et)
HU (1) HUP0100335A3 (et)
IL (1) IL135738A0 (et)
NO (1) NO20002967L (et)
PL (1) PL341060A1 (et)
PT (1) PT1060162E (et)
SK (1) SK8612000A3 (et)
TR (1) TR200001635T2 (et)
WO (1) WO1999029669A1 (et)
YU (1) YU35600A (et)
ZA (1) ZA9811262B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072865A1 (en) * 2001-01-15 2004-04-15 Bouillot Anne Marie Jeanne Aryl piperidine derivatives as inducers of ldl-receptor expression
JP2004520347A (ja) * 2001-01-15 2004-07-08 グラクソ　グループ　リミテッド Ｌｄｌ−受容体発現のインデューサーとしてのアリールピペリジンおよびピペラジン誘導体
EP1351937A1 (en) * 2001-01-15 2003-10-15 Glaxo Group Limited Aryl piperidine derivatives as inducers of ldl-receptor expression
DE10132686A1 (de) * 2001-07-05 2003-01-16 Boehringer Ingelheim Pharma Heteroarylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
JP4664634B2 (ja) * 2003-09-05 2011-04-06 富山化学工業株式会社 新規なベンズアミジン誘導体またはその塩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04312572A (ja) * 1991-04-12 1992-11-04 Takeda Chem Ind Ltd 環状アミン化合物
DE4407138A1 (de) 1994-03-04 1995-09-07 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4407136A1 (de) 1994-03-04 1995-09-07 Thomae Gmbh Dr K Aroyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
HUP0100335A3 (en) 2001-11-28
EP1060162A1 (de) 2000-12-20
BR9813495A (pt) 2000-10-10
DE19754796A1 (de) 1999-06-17
CN1281434A (zh) 2001-01-24
DK1060162T3 (da) 2003-07-14
HUP0100335A2 (hu) 2001-07-30
JP2001525397A (ja) 2001-12-11
CO5370694A1 (es) 2004-02-27
WO1999029669A1 (de) 1999-06-17
KR20010032977A (ko) 2001-04-25
HRP20000377A2 (en) 2000-12-31
PL341060A1 (en) 2001-03-26
TR200001635T2 (tr) 2000-11-21
YU35600A (sh) 2002-09-19
PT1060162E (pt) 2003-08-29
DE59807591D1 (de) 2003-04-24
JP3418688B2 (ja) 2003-06-23
ZA9811262B (en) 2000-06-09
NO20002967D0 (no) 2000-06-09
SK8612000A3 (en) 2000-11-07
AU1759499A (en) 1999-06-28
ES2190130T3 (es) 2003-07-16
EE200000342A (et) 2001-08-15
BG104500A (bg) 2001-03-30
ATE234816T1 (de) 2003-04-15
AR017827A1 (es) 2001-10-24
EP1060162B1 (de) 2003-03-19
EA200000631A1 (ru) 2000-12-25
IL135738A0 (en) 2001-05-20
CA2309388A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
WO1999033858A3 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
TR200100439T2 (tr) 1H-İmidazopiridin türevleri
WO2003062259A3 (en) Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
CO5570660A2 (es) Indazolilpirrolotriazinas c-6 modificadas
EP1031563A4 (en) SULFONYL DERIVATIVES
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
SE9904652D0 (sv) Novel Compounds
NO980856D0 (no) Piperazinderivater og fremgangsmåte for fremstilling derav
YU49443B (sh) Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija
DK1265606T3 (da) Celleadhæsionsinhibitorer
GB2303851A (en) Pharmaceutical diketopiperazine compounds
TW200510377A (en) Novel compound having 4-pyridylalkylthio group as substituent
NO20002589L (no) Bifenylamidinderivater
ATE157969T1 (de) Diaminotrifluoromethylpyrimidinderivate, verfahren zu ihrer herstellung und diese enthaltende phospholipase-a2-inhibitoren
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
ATE238297T1 (de) Chinolinderivat
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
WO1998053790A3 (en) Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
PL361850A1 (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
ES2069668T3 (es) Composiciones biocidas.
SE8303913D0 (sv) Heterocykliska foreningar
WO2001079170A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
NO975402L (no) Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application